News | Cath Lab | December 28, 2015

Boston Scientific Chariot Guiding Sheath May Break off During Procedures

December 28, 2015 — The U.S. Food and Drug Administration (FDA) said Boston Scientific has started a Class I recall of its Chariot Guiding Sheath after receiving 14 complaints of the shaft of the device separating. This can cause small pieces to break off the device and enter the patient’s bloodstream. 

The FDA said these emboli might obstruct blood flow and require additional interventions to remove device fragments. Obstructed blood flow can result in serious patient injuries such as stroke, kidney damage, damage to the intestines or limbs, or can cause patient death.

On Dec. 15, Boston Scientific sent an urgent medical device recall removal letter to their customers. In the letter they instructed customers to immediately stop using and quarantine any affected products. These products should be returned to the vendor.

Additionally, physicians are encouraged to contact all patients who have undergone procedures involving Chariot to confirm their post-procedure status, as device shaft separation and embolized fragments may not have been recognized at the time of the procedure.

The U.S. recall includes 5,692 units nationwide. The affected device manufacturing dates and between March 17, 2015 to Nov. 10, 2015 and had distribution dates from June 6, 2015 to Nov. 17, 2015

The Chariot Guiding Sheath is used to guide the placement of interventional and diagnostic devices into the veins and arteries of a patient’s arms, hands, legs or feet (peripheral vasculature).

The recall affects all UPNs of the Chariot Guiding Sheaths:

  • H74939277645110
  • H74939277745110
  • H74939277845110
  • H74939277645220
  • H74939277765120
  • H74939277690210
  • H74939277665110
  • H74939277790110
  • H74939277645120
  • H74939277865120
  • H74939277690220
  • H74939277690110
  • H74939277865110
  • H74939277745120
  • H74939277890120
  • H74939277845210
  • H74939277765110
  • H74939277545210
  • H74939277790210
  • H74939277845120
  • H74939277745210
  • H74939277545110
  • H74939277790220
  • H74939277790120
  • H74939277745220
  • H74939277645210
  • H74939277690120
  • H74939277665120
  • H74939277890110

Physicians and health care facilities with questions can contact their Boston Scientific representative or call (800) 811-3211.


Related Content

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init